Jan Gaertig
机构:LMU Klinikum, Ludwig-Maximilians-Universität München
发表论文 14 篇 · 总被引 8 次 · h-index 2
代表论文
- Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity (2025 · JHEP Reports · 被引 5)
- Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor–Induced Colitis Compared with Ulcerative Colitis (2025 · Cancer Immunology Research · 被引 3)
- Supplementary Figure 2 from Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor–Induced Colitis Compared with Ulcerative Colitis (2025)
- Supplementary Figure 6 from Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor–Induced Colitis Compared with Ulcerative Colitis (2025)
- Supplementary Table 2 from Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor–Induced Colitis Compared with Ulcerative Colitis (2025)
- Supplementary Figure 3 from Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor–Induced Colitis Compared with Ulcerative Colitis (2025)